Blackhawk Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,267
Closed -$941K – 187
2026
Q2
$941K Sell
10,267
-262
-2% -$22.9K 0.31% 73
2026
Q1
$897K Sell
10,529
-1,226
-10% -$109K 0.33% 67
2025
Q4
$929K Buy
+11,755
New +$922K 0.35% 70
2021
Q1
– Sell
-7,812
Closed -$603K – 93
2020
Q4
$603K Sell
7,812
-1,099
-12% -$90.9K 0.52% 58
2020
Q3
$653K Sell
8,911
-3,606
-29% -$275K 0.59% 53
2020
Q2
$831K Sell
12,517
-1,029
-8% -$73.1K 0.99% 40
2020
Q1
$933K Buy
+13,546
New +$955K 0.83% 48
2018
Q4
– Sell
-8,286
Closed -$555K – 75
2018
Q3
$555K Buy
8,286
+1,516
+22% +$101K 0.78% 38
2018
Q2
$439K Buy
6,770
+414
+7% +$27.1K 0.5% 54
2018
Q1
$456K Buy
6,356
+576
+10% +$41.5K 0.39% 62
2017
Q4
$436K Buy
+5,780
New +$422K 0.38% 66

Other funds holding CL

Blackhawk Capital Partners's CL Position: Q3 2026 in Review

Blackhawk Capital Partners sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 10,267 shares — an estimated $941K sold.

Blackhawk Capital Partners first reported a position in CL in Q4 2017 and held it in 11 quarters. The position peaked at $941K in Q2 2026. 1,967 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Blackhawk Capital Partners reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Blackhawk Capital Partners sold 10,267 Colgate-Palmolive shares in Q3 2026, an estimated $941K.
  • Blackhawk Capital Partners first reported a position in Colgate-Palmolive in Q4 2017 and held it in 11 quarters.
  • Blackhawk Capital Partners's Colgate-Palmolive position peaked at $941K in Q2 2026.
  • 1,967 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Blackhawk Capital Partners's 13F filing for Q3 2026, filed 10 Nov 2026.